252 related articles for article (PubMed ID: 32010625)
1. Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells.
San-Millán I; Julian CG; Matarazzo C; Martinez J; Brooks GA
Front Oncol; 2019; 9():1536. PubMed ID: 32010625
[TBL] [Abstract][Full Text] [Related]
2. Role of Lactate in the Regulation of Transcriptional Activity of Breast Cancer-Related Genes and Epithelial-to-Mesenchymal Transition Proteins: A Compassion of MCF7 and MDA-MB-231 Cancer Cell Lines.
San-Millan I; Martinez JL; Pickard SL; Yu H; Hirsch FR; Rivard CJ; Brooks GA
bioRxiv; 2023 Sep; ():. PubMed ID: 36993762
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
[TBL] [Abstract][Full Text] [Related]
4. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression.
Pandkar MR; Sinha S; Samaiya A; Shukla S
Transl Oncol; 2023 Nov; 37():101758. PubMed ID: 37572497
[TBL] [Abstract][Full Text] [Related]
5. [Heregulin-β1-induced Glycolysis Promotes Migration of Breast Cancer Cell Line MCF7].
Jiang SF; Tu KL; Zhou L; Fu Q; Zhao YH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):463-467. PubMed ID: 28591943
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
7. High extracellular lactate causes reductive carboxylation in breast tissue cell lines grown under normoxic conditions.
Brodsky AN; Odenwelder DC; Harcum SW
PLoS One; 2019; 14(6):e0213419. PubMed ID: 31181081
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer.
Yousefi A; Sotoodehnejadnematalahi F; Nafissi N; Zeinali S; Azizi M
Sci Rep; 2024 Mar; 14(1):5845. PubMed ID: 38462658
[TBL] [Abstract][Full Text] [Related]
9. ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis.
De Vitis C; Battaglia AM; Pallocca M; Santamaria G; Mimmi MC; Sacco A; De Nicola F; Gaspari M; Salvati V; Ascenzi F; Bruschini S; Esposito A; Ricci G; Sperandio E; Massacci A; Prestagiacomo LE; Vecchione A; Ricci A; Sciacchitano S; Salerno G; French D; Aversa I; Cereda C; Fanciulli M; Chiaradonna F; Solito E; Cuda G; Costanzo F; Ciliberto G; Mancini R; Biamonte F
J Exp Clin Cancer Res; 2023 Mar; 42(1):69. PubMed ID: 36945054
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells.
Meadows AL; Kong B; Berdichevsky M; Roy S; Rosiva R; Blanch HW; Clark DS
Biotechnol Prog; 2008; 24(2):334-41. PubMed ID: 18307352
[TBL] [Abstract][Full Text] [Related]
11. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
12. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
Dang CV; Le A; Gao P
Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
[TBL] [Abstract][Full Text] [Related]
13. Effects of Intermittent Hypoxia on Expression of Glucose Metabolism Genes in MCF7 Breast Cancer Cell Line.
Jarrar Y; Zihlif M; Al Bawab AQ; Sharab A
Curr Cancer Drug Targets; 2020; 20(3):216-222. PubMed ID: 31738135
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines.
Bernard-Gallon DJ; Vissac-Sabatier C; Antoine-Vincent D; Rio PG; Maurizis JC; Fustier P; Bignon YJ
Br J Nutr; 2002 Apr; 87(4):281-9. PubMed ID: 12064337
[TBL] [Abstract][Full Text] [Related]
15. Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators.
Ghozlan H; Showalter A; Lee E; Zhu X; Khaled AR
Front Oncol; 2021; 11():663877. PubMed ID: 33996588
[TBL] [Abstract][Full Text] [Related]
16.
Karimpur Zahmatkesh A; Khalaj-Kondori M; Hosseinpour Feizi MA; Baradaran B
EXCLI J; 2023; 22():847-861. PubMed ID: 37780942
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-mediated nuclear accumulation of lactate promotes epigenetic alterations to induce cancer cell proliferation.
Bandopadhyay S; Kamal IM; Padmanaban E; Ghosh DD; Chakrabarti S; Roy SS
J Cell Biochem; 2023 Apr; 124(4):495-519. PubMed ID: 36999756
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
19. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches.
de la Cruz-López KG; Castro-Muñoz LJ; Reyes-Hernández DO; García-Carrancá A; Manzo-Merino J
Front Oncol; 2019; 9():1143. PubMed ID: 31737570
[TBL] [Abstract][Full Text] [Related]
20. Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications.
Mortazavi Farsani SS; Verma V
Front Oncol; 2023; 13():1175532. PubMed ID: 37234972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
